Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Swedish Heart & Vascular Institute (SHVI) is a leading cardiovascular care center based in Seattle, Washington, and serves as a specialized division of Swedish Health Services. The institute provides a comprehensive range of services, including interventional cardiology, cardiac surgery, electrophysiology, and vascular surgery. SHVI is recognized for its high-volume clinical programs and its significant involvement in clinical research, frequently serving as a primary site for Phase 1 through Phase 3 clinical trials for innovative cardiovascular devices and therapies. As a major regional referral center, it offers advanced treatments such as transcatheter aortic valve replacement (TAVR) and complex arrhythmia management. The institute is integral to the Pacific Northwest's healthcare infrastructure, combining clinical excellence with a robust research mission.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swedish Heart & Vascular Institute.